Cargando…

PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents

Detalles Bibliográficos
Autores principales:	Calzada-Hernández, J, Noguera Julian, A, Ricart Campos, S, Bou Torrent, R, Iglesias Jiménez, E, González Fernández, MI, Sánchez Manubens, J, Torrente Segarra, V, Rozas Quesada, L, Martín Carpi, FJ, Antón López, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045709/ http://dx.doi.org/10.1186/1546-0096-11-S2-P255

Ejemplares similares

PReS-FINAL-1014: Role of MHC class I overexpression on muscle biopsy of patients with juvenile dermatomyositis
por: Sanchez-Manubens, J, et al.
Publicado: (2013)

Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study
por: Calzada-Hernández, Joan, et al.
Publicado: (2015)

PReS-FINAL-2310: Successful rituximab treatment in a 14 year-old boy with lupus nephritis
por: Torrente-Segarra, V, et al.
Publicado: (2013)

Efficacy and safety of TNF-alpha antagonists in children with juvenile idiopathic arthritis who started treatment under 4 years of age
por: Roca, Clara Giménez, et al.
Publicado: (2014)

PReS-FINAL-2309: Juvenile systemic lupus erythematosus: a case series depiction in an urban community and a comparison to an adult case series
por: Torrente-Segarra, V, et al.
Publicado: (2013)

PReS-FINAL-1013: Magnetic resonance imaging as a non-invasive tool to assess muscle edema in juvenile dermatomyositis. Return to normal after treatment
por: Iglesias, E, et al.
Publicado: (2013)

PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
por: Gonzalez Fernandez, MI, et al.
Publicado: (2013)

Clinical depiction, treatment and long term follow up characterization of a group of enthesitis related arthritis - juvenile idiopathic arthritis patients from a spanish pediatric tertiary hospital
por: Baldizon, Samuel Hernandez, et al.
Publicado: (2014)

Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
por: Ricart, S, et al.
Publicado: (2011)

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013)

PReS-FINAL-2334: Chronic recurrent multifocal osteomyelitis and tnf-αlfa inhibitors
por: Alberdi-Saugstrup, M, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

Incidence and clinical features of kawasaki disease in Catalonia (Spain)
por: Sanchez-Manubens, Judith, et al.
Publicado: (2014)

PReS-FINAL-2048: Treatment with methotrexate plus leflunomide for juvenile idiopathic arthritis
por: Quesada-Masachs, E, et al.
Publicado: (2013)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

2265. The Changing Landscape of AIDS Defining CNS Infections in S. Alberta, Canada Over 30 Years
por: Lang, Raynell, et al.
Publicado: (2018)

2265. Immunocompromised Patients, Compromised Guidelines? Practice Patterns of Managing Asymptomatic Bacteriuria in Immunocompromised Patients
por: Moore, Jacqueline, et al.
Publicado: (2023)

Prospective analysis of Kawasaki disease cases in Catalonia (Spain) from March 2013 to March 2014
por: Sanchez-Manubens, Judith, et al.
Publicado: (2014)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

PReS-FINAL-2064: Effect of Goloimumab a new anti-TNF, in patients with the diagnosis of juvenile idiopathic arthritis
por: Kienast, A, et al.
Publicado: (2013)

PB2265: RISK FACTORS FOR DISEASE PROGRESSION OF MYCOSIS FUNGOIDES AND SÉZARY SYNDROME IN EAST ASIAN POPULATION
por: Wu, Huai-Chueh Gem, et al.
Publicado: (2023)

PReS-FINAL-2210: Qualitative aspects of autoinflammatory diseases
por: Konukbay, D, et al.
Publicado: (2013)

PReS-FINAL-1010: circulating micrornas in traps
por: Lucherini, OM, et al.
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)
por: Torrente-Segarra, V, et al.
Publicado: (2011)

PReS-FINAL-2090: Efficacy of anti-TNF drugs from the perspective of growth velocity: a single center experience
por: Mrážik, P, et al.
Publicado: (2013)

PReS-FINAL-2337: The eurofever registry: 3 years of enrollment
por: Federici, S, et al.
Publicado: (2013)

PReS-FINAL-2336: Induction of MDSCS in Muckle-Wells syndrome
por: Rieber, N, et al.
Publicado: (2013)

OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients
por: Iwasa, Yoh-ichiro, et al.
Publicado: (2019)

2265. Clinical Outcomes with Single vs. Combination Antibiotic Therapy in the Treatment of Burkholderia cepacia complex Bacteremia and Pneumonia
por: George, G Taylor A, et al.
Publicado: (2019)

2265 Effect of dietary approaches to stop hypertension (DASH) diet on hemodynamic markers in advanced heart failure patients
por: Sattler, Elisabeth L. P., et al.
Publicado: (2018)

PReS-FINAL-2287: Electroconvulsive therapy in a patient with juvenile systemic lupus erythematous
por: Bica, BE, et al.
Publicado: (2013)

PReS-FINAL-2331: Low-penetrance NLRP3 variants
por: Endres, T, et al.
Publicado: (2013)

PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis
por: Sarychev, A, et al.
Publicado: (2013)

PReS-FINAL-2127: Sclerodermatous graft versus host disease
por: Stevenson, JR, et al.
Publicado: (2013)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

PReS-FINAL-2329: Validation of the autoinflammatory activity index (AIDAI)
por: Piram, M, et al.
Publicado: (2013)

PReS-FINAL-2259: Spectrum of Sjögren syndrome in children
por: Bica, BE, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ld8rnug4udb7tiufemj1tknd63